EPRX — Eupraxia Pharmaceuticals Inc Institutional Holders · Q2 2026

Name: Who Owns EPRX? 73 Institutions Hold $164M (Q2 2026)
Creator: ko.io

Who owns Eupraxia Pharmaceuticals Inc (EPRX)? 73 institutions reported holding $163.57M in SEC 13F filings for Q2 2026 (period ended 2026-06-30). Largest holders: Beutel, Goodman & Co Ltd. ($23.8M), Affinity Asset Advisors, LLC ($10.9M), Balyasny Asset Management L.P. ($8.9M).

Rank	Institution	Value	Shares	Change
1	Beutel, Goodman & Co Ltd.	$23.8M	3.6M	Trimmed
2	Affinity Asset Advisors, LLC	$10.9M	1.6M	Added
3	Balyasny Asset Management L.P.	$8.9M	1.4M	Added
4	Vivo Capital, LLC	$8.9M	1.4M	Hold
5	SCOTIA CAPITAL INC.	$8.8M	1.3M	Added
6	PFM Health Sciences, LP	$8.0M	1.2M	Added
7	GREAT POINT PARTNERS LLC	$7.9M	1.2M	Hold
8	Jupiter Topco LLC	$6.9M	1.0M	New
9	Rubric Capital Management LP	$5.7M	867,424	Added
10	Ikarian Capital, LLC	$5.4M	809,741	Trimmed
11	Woodline Partners LP	$4.9M	746,864	Added
12	Point72 Asset Management, L.P.	$4.8M	730,284	Trimmed
13	AMERIPRISE FINANCIAL INC	$4.7M	711,024	Added
14	Redmile Group, LLC	$4.0M	611,400	Trimmed
15	Seven Fleet Capital Management LP	$4.0M	610,785	Trimmed
16	UBS Group AG	$3.4M	519,211	Trimmed
17	CITADEL ADVISORS LLC	$3.3M	502,011	Added
18	MILLENNIUM MANAGEMENT LLC	$2.9M	441,586	New
19	Alyeska Investment Group, L.P.	$2.5M	375,000	Hold
20	PICTON MAHONEY ASSET MANAGEMENT	$2.4M	360,878	New
21	Velan Capital Investment Management LP	$2.3M	352,000	Hold
22	JANE STREET GROUP, LLC	$2.2M	329,053	Added
23	Aisling Capital Management LP	$2.1M	325,000	Hold
24	SummitTX Capital, L.P.	$2.1M	318,784	Trimmed
25	Royal Bank of Canada	$2.1M	311,435	Added

Source: SEC Form 13F filings · as of 2026-06-30